A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alberto Briganti, MD
Vita-Salute University San Raffaele
Principal Investigator - Alexander K Nosov, MD
Research Institute of Oncology n.a. Professor N.N. Petrov under the Federal Agency for Healthcare and Social Development
Principal Investigator - Bertram Yuh, MD
City of Hope National Cancer Center
Principal Investigator - Boris Ya Alexeev, MD
Moscow Oncology Research Institute n.a. P.A. Hertsen
Principal Investigator - David Jarrard, MD
University of Wisconsin, Madison
Principal Investigator - Douglas Scherr, M.D.
New York Presbyterian Hospital-Cornell
Principal Investigator - Edouard Trabulsi, MD
Thomas Jefferson University / Jefferson Urology Associates
Principal Investigator - Eric Klein, MD
Glickman Urology & Kidney Institute, Cleveland Clinic
Principal Investigator - Geza Boszormenyi-Nagy, MD
Bajcsy-Zsilinszky Hospital, Department of Urology
Principal Investigator - Henryk Zielinski, MD
University Hospital Plzen, Department of Urology
Principal Investigator - Istvan Buzogany, MD
Peterfy Sandor Street Hospital, Department of Urology
Principal Investigator - Jeffrey Karnes, MD
Mayo Clinic
Principal Investigator - Jerzy Sokolowski, MD, PhD
Provincial Specialist Hospital in Wroclaw, Department of Urology
Principal Investigator - Josef Stolz, MD
University Hospital Motol, Clinic of Urology
Principal Investigator - Judd Moul, MD
Duke University
Principal Investigator - Kevin Slawin, MD
University of Texas Vanguard Urologic Research Foundation
Principal Investigator - Marcin Matuszewski, MD, PhD
University Clinical Centre, Department of Urology
Principal Investigator - Marek Krolupper, MD
Hospital Na Bulovce, Department of Urology
Principal Investigator - Michael Pesl,, MD
General University Hospital in Prague, Clinic of Urology
Principal Investigator - Michiel Sedelaar, MD
UMC St. Radboud Nijmegen
Principal Investigator - Mikhail I Shkolnik, MD
Federal State Public Institution Russian Research center for Radiology and Surgical Technologies under the Federal agency for High-tech medical care
Principal Investigator - Milan Hora, MD, PhD
University Hospital Plzen, Department of Urology
Principal Investigator - Oleg B Karyakin
Federal State Public Institution "Medical Radiology Research Center" of Healthcare Ministry and Social Development of Russian Federation
Principal Investigator - Paolo Gontero, MD
University of Turin, Italy
Principal Investigator - Peter Tenke, MD
Jahn Ferenc South Pest Hospital, Department of Urology
Principal Investigator - Petr A Karlov, MD
St. Petersburg State Public Medical Institution: "Clinical Oncological Center"
Principal Investigator - Roman Zachoval,, MD, PhD, MBA
Thomayer's Hospital
Principal Investigator - Sergey B Petrov, MD
All-Russia Centre for Urgent Care and Radiation Medicine named after A.M. Nikiforov under the Ministry of the Russian Federation for Civil Defence, Emergencies and Elimination of Consequences of Natural Disasters
Principal Investigator - Sergey V Mishugin, MD
City Clinical Hospital # 57
Principal Investigator - Steven Joniau, MD
Universitaire Ziekenhuizen KU Leuven
Principal Investigator - Thomas Keane, MD
Medical University of South Carolina
Principal Investigator - Tomasz Szydelko, MD, PhD
4th Military Teaching Hospital and Polyclinic,
Principal Investigator - Vladimir Student, MD, PhD
University Hospital Olomouc, Clinic of Urology
Principal Investigator - Vsevolod B Matveev, MD
Federal Public State Institution "Russian Oncology Research Center n.a. N.N. Blokhin under the Russian Academy of medical sciences"
Principal Investigator - William Ellis, MD
University of Washington
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospitals Leuven
Leuven, Belgium
- University Hospital Olomouc, Clinic of Urology
Olomouc, Czechia
- University Hospital Plzen, Department of Urology
Pilsen, Czechia
- General University Hospital in Prague, Clinic of Urology
Prague, Czechia
- Hospital Na Bulovce, Department of Urology
Prague, Czechia
- Thomayer'S Hospital
Prague, Czechia
- University Hospital Motol, Clinic of Urology
Prague, Czechia
- Bajcsy-Zsilinszky Hospital, Department of Urology
Budapest, Hungary
- Jahn Ferenc South Pest Hospital, Department of Urology
Budapest, Hungary
- Peterfy Sandor Street Hospital, Department of Urology
Budapest, Hungary
- Vita-Salute University San Raffaele
Milan, Italy
- University of Turin
Torino, Italy
- Umc St. Radboud Nijmegen
Nijmegen, Netherlands
- University Clinical Centre, Department of Urology
Gdansk, Poland
- University Hospital Plzen, Department of Urology
Warsaw, Poland
- "provincial Specialist Hospital in Wroclaw, Department of Urology
Wroclaw, Poland
- 4th Military Teaching Hospital and Polyclinic,
Wroclaw, Poland
- City Clinical Hospital # 57
Moscow, Russia
- Federal Public State Institution "russian Oncology Research Center N.A. N.N. Blokhin Under the Russian Academy of Medical Sciences"
Moscow, Russia
- Moscow Oncology Research Institute N.A. P.A. Hertsen
Moscow, Russia
- Federal State Public Institution "medical Radiology Research Center" of Healthcare Ministry and Social Development of Russian Federation
Obninsk, Russia
- All-Russia Centre for Urgent Care and Radiation Medicine Named After A.M. Nikiforov Under the Ministry of the Russian Federation for Civil Defence, Emergencies and Elimination of Consequences of Natural Disasters
Saint Petersburg, Russia
- Federal State Public Institution Russian Research Center for Radiology and Surgical Technologies Under the Federal Agency for High-Tech Medical Care
Saint Petersburg, Russia
- Research Institute of Oncology N.A. Professor N.N. Petrov Under the Federal Agency for Healthcare and Social Development
Saint Petersburg, Russia
- St. Petersburg State Public Medical Institution: "clinical Oncological Center"
Saint Petersburg, Russia
- City of Hope National Cancer Center
Duarte, California, United States
- Mayo Clinic
Rochester, Minnesota, United States
- New York Presbyterian Hospital - Cornell
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Glickman Urology & Kidney Institute, Cleveland Clinic
Cleveland, Ohio, United States
- Thomas Jefferson University / Jefferson Urology Associates
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas Vanguard Urologic Research Foundation
Houston, Texas, United States
- University of Washington School of Medicine
Seattle, Washington, United States
- University of Wisconsin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2012
- Primary completion
- 31 Dec 2013
- Completion
- 31 Dec 2013
- Last update posted
- 7 Feb 2017
- Registered enrollment
- 105
- Registry id
- NCT01667536
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.